TickerFactsScreenerDevelopers

TENAX THERAPEUTICS, INC. (TENX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$8.40M2012: -$8.28M2013: -$4.92M2014: -$9.26M2015: -$9.75M2016: -$15.87M2017: -$12.14M2018: -$5.50M2019: -$7.56M2020: -$9.27M2021: -$10.86M2022: -$11.39M2023: -$5.90M2024: -$14.81M2025: -$35.80M-$35.80M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$35.80M-141.7%
2024-$14.81M-150.9%
2023-$5.90M+48.2%
2022-$11.39M-4.9%
2021-$10.86M-17.1%
2020-$9.27M-22.7%
2019-$7.56M-37.4%
2018-$5.50M+54.7%
2017-$12.14M+23.5%
2016-$15.87M-62.8%
2015-$9.75M-5.3%
2014-$9.26M-88.2%
2013-$4.92M+40.6%
2012-$8.28M+1.5%
2011-$8.40M—